Article
Radix Sophorae Flavescentis (Kushen) inhibits NSCLC by targeting miR-183-5p/EGR1 and PTEN/AKt pathway
2022-11-07
Abstract excerpt
<h4>Background: </h4> Radix Sophorae Flavescentis (Kushen) is the principal herb consisting of Compound Kushen Injection (CKI), which has been approved for the clinical treatment of tumors. Although CKI has been widely used, especially on non-small cell lung cancer (NSCLC), its underlying mechanisms of Kushen regarding microRNA-target gene-pathway remain unclear. Methods A549 cell line was selected as the NSCLC m...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a5a1c477-3e8a-57d7-8d06-e7056d577cb2
- DOI
- 10.21203/rs.3.rs-2227945/v1
